Bruno Lucidi - Jun 18, 2021 Form 4 Insider Report for Atea Pharmaceuticals, Inc. (AVIR)

Role
Director
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Bruno Lucidi
Stock symbol
AVIR
Transactions as of
Jun 18, 2021
Transactions value $
$0
Form type
4
Date filed
6/21/2021, 05:36 PM
Next filing
Jun 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVIR Stock Option (Right to Buy) Award $0 +34K $0.00 34K Jun 18, 2021 Common Stock 34K $23.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in twelve (12) equal monthly installments following June 18, 2021, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.